Three Portfolio Companies of Hetang Venture Capital Enter China's Innovative Medical Device Special Review Program

Origo Biotechnology is a research and development enterprise focused on clinical applications of musculoskeletal regenerative medical materials. It was jointly established by Professor Fan Shunwu's orthopedic team from Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and the medical device industry. The company adoptsThe "Clinical-Research-Clinical" development model has led to the creation of several innovative implant material products for bone tissue repair, hard tissue adhesion, and soft tissue regeneration.

Fig: Bone Adhesive Materials

Hangzhou Juzheng Medical Technology Co., Ltd. is a national high-tech enterprise specializing in the development of disruptive medical devices for vascular interventional therapy, dedicated to providing new treatment options for patients with cardiovascular and cerebrovascular diseases. The company's founders and core team members consist of renowned experts in China’s biomaterials field and R&D management teams from well-known medical device companies both in China and abroad, possessing extensive experience in the research and development of implantable and interventional medical device products as well as project management.

Figure: Disposable Intracranial Laser Balloon

Ronghe Healthcare focuses on the research and development and industrialization of original medical devices in the field of respiratory intervention, and is one of the few companies in China that concentrate on this area."Innovative enterprises in the细分赛道 of 'Interventional Treatment for Chronic Obstructive Pulmonary Disease (COPD).' The company has gathered an interdisciplinary team consisting of interventional respiratory physicians, medical device engineering experts, and bioelectric field physics researchers, possessing full-chain development capabilities from materials, devices, navigation systems to clinical applications."

Fig: Real-time Electromagnetic Navigation Pulsed Electric Field Ablation System

About Hetang Ventures

Hetang Ventures is a venture capital fund management institution held by Beijing Tsinghua Industrial Development Research Institute,Restructured in 2014 under the strategic backdrop of promoting the transformation of scientific and technological achievements in universities, it is a professional investment management institution primarily focused on early-stage investments in science and technology innovation enterprises. Hotang Ventures concentrates on key fields such as life sciences, medical devices, information technology, and modern manufacturing. It has long been dedicated to investing in innovative enterprises with core hard technologies, while also specializing in incubation investments based on the scientific and technological achievements of university and top-tier hospital clinical experts. Hotang Ventures currently manages funds nearing 4 billion yuan, with over 100 accumulated investment projects. It supports scientists and entrepreneurs with significant research discoveries and technological innovations in implementing their results, achieving "commercial transformation from 0 to 1." At the same time, it consistently adheres to selecting high-barrier “first-of-its-kind technologies” for early-stage investment. With outstanding performance, Hotang Ventures has received honors such as being ranked in the “Top 50 Early-Stage Investment Institutions in China” by Rongzhong and “Top 50 Best Early-Stage Venture Capital Institutions in China” by Touzhong.